Sickle cell disease is a hereditary condition, which means a person inherits it from their biological parents. The condition occurs when a person inherits two copies of the hemoglobin beta (HBB) gene ...

Sickle cell disease is inherited at birth when you receive related genes from both parents. One gene usually causes sickle cell trait (SCT), which often has no health problems. The main sickle cell ...

Sickle cell disease is the first genetic disease ever identified, and yet for too many patients, particularly those in the Black community, the care has not kept up with the science. Dr. Ashley Ellis ...

Near-infrared spectroscopy (NIRS), an optical tool that leverages light-tissue interaction to measure changes in hemoglobin concentration and oxygenation, has been used in a variety of fields due to ...

Sickle cell disease (SCD) can affect people of any ethnicity but is much more common among Africans and African Americans. Other ethnic groups with higher rates of SCD include Hispanic Americans from ...

How is it that you’re alive? It’s a question that we rarely ask ourselves—but it’s one that has a definite answer. We all know our heart pumps life-giving oxygen throughout our bodies. How does that ...

Contrary to misconceptions among medical professionals and patients alike, individuals born with sickle cell trait (SCT) show no risk of experiencing the acute pain crises known to occur with sickle ...

Stable production of anti-sickling adult hemoglobin (HBA T87Q) and elimination or significant reduction of vaso-occlusive events sustained through last follow-up for all evaluable patients (n=38), ...

“Think of the blood vessels like a city highway,” says Elizabeth Margolskee, MD, MPH, a clinical pathologist and an associate professor of clinical pathology and laboratory medicine at the Perelman ...

This article is part of The Athletic’s series marking UK Black History Month. To view the whole collection, click here. Lassana Diarra was preparing for the 2010 World Cup in South Africa. The ...

SOMERVILLE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (Nasdaq: BLUE) today announced that new and updated data from its lentiviral vector (LVV) gene addition programs in patients with sickle cell ...